MSMainak Sinha

Mainak Sinha

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mainak Sinha has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Overcoming resistance in glioblastoma immunotherapy: lessons from the past and opportunities for the future

    by Rijhul Lahariya, Mainak Sinha

    Glioblastoma (GBM) is the most aggressive primary brain tumor in adults, characterized by rapid proliferation, diffuse invasion, and profound therapeutic resistance, leading to a median survival of approximately 15 months despite maximal treatment. Immunotherapy, which has transformed outcomes in other malignancies, has shown limited success in GBM due to its immune-privileged environment, extensive immunosuppressive networks, and tumor heterogeneity. Clinical trials of checkpoint inhibitors, cancer vaccines, CAR-T cells, oncolytic viruses, and microenvironment-targeting agents have largely failed to produce durable survival benefits, often hindered by poor T-cell infiltration, antigen loss, and redundant suppressive mechanisms within the tumor microenvironment. Lessons from these failures highlight the necessity of mechanism-informed strategies that address the tumor's immune evasion. Next-generation approaches emphasize priming the tumor to enhance immune visibility, targeting multiple antigens to prevent escape, optimizing locoregional CAR-T delivery, using oncolytic viruses as immune catalysts rather than sole cytotoxic agents, and strategically modulating the microenvironment to support effector responses. By integrating these insights, rational combination strategies can transform GBM immunotherapy from incremental efficacy to meaningful clinical benefit. Translational rigor, adaptive trial designs, and biology-driven interventions are essential to overcoming the complex barriers posed by GBM and achieving durable anti-tumor immunity.

  • A rare case of hemoptysis due to Paragonimus westermanii: The tip of an iceberg?

    by Vishnu Shankar Ojha, Sona Bhardwaj, Saraj Kumar Singh, Mainak Sinha

  • Top Cited Papers

    Time-dependent neurovascular unit dysfunction in ischemic stroke: mechanisms of neurovascular uncoupling and its clinical impact

    by Rijhul Lahariya, Mainak Sinha, Bandana Kumari, Keyush Venket Subramanian, Gargee Anand

    Neurovascular unit (NVU) dysfunction is a central determinant of tissue injury, reperfusion failure, and long-term neurological outcomes after ischemic stroke. This review critically examines the cellular and molecular mechanisms underlying NVU disruption, with a particular focus on inflammation, oxidative stress, and blood-brain barrier (BBB) integrity, and evaluates emerging NVU-targeted therapeutic strategies. A focused narrative review synthesized studies on ischemic stroke-related NVU alterations, integrating cellular mechanisms, biomarkers, and phase-specific therapeutic strategies targeting BBB dysfunction, inflammation, oxidative stress, and neurorestoration. Acute ischemic injury induces endothelial tight-junction disruption, pericyte constriction and loss, astrocytic activation, and microglial-driven inflammation, resulting in BBB breakdown, impaired neurovascular coupling, and restricted microvascular reperfusion. These processes facilitate leukocyte infiltration, exacerbate secondary neuronal damage, and increase hemorrhagic transformation risk. Circulating and cerebrospinal fluid biomarkers, including MMP-9, GFAP, S100B, and pro-inflammatory cytokines, reflect NVU injury severity and correlate with functional outcomes. In the chronic phase, persistent BBB permeability, maladaptive VEGF signaling, and sustained low-grade inflammation contribute to white matter injury, impaired neuroplasticity, and post-stroke cognitive decline. Therapeutic strategies targeting NVU dysfunction include anti-inflammatory agents, COX-2 inhibitors, and NADPH oxidase inhibitors, alongside stem cell-based and extracellular vesicle-mediated approaches that promote vascular stabilization and repair. Neuroplasticity-enhancing interventions and nanoparticle-based drug delivery systems further support functional recovery. NVU dysfunction underlies both acute injury amplification and chronic recovery failure after stroke. Biomarker-guided, phase-specific therapeutic strategies targeting inflammation, oxidative stress, and BBB instability represent a promising framework for personalized stroke management.


  • Open Access

    Influence of Early Exposure and Educational Gaps on Medical Students: A Career-Driven Strategy for Aspiring Neurosurgeons

    by Mainak Sinha, Rijhul Lahariya, Anand Kumar Das, Saraj Kumar Singh

    Neurosurgery is a high-demand specialty in medicine, yet the factors influencing medical students' decision to pursue it remain underexplored. This study aimed to evaluate the demographics, academic year-wise interest, motivating and deterring factors, and the role of undergraduate exposure in influencing students' intentions to pursue neurosurgery. A cross-sectional survey of 503 Bachelor of Medicine, Bachelor of Surgery (MBBS) students across India was conducted. The survey assessed demographics, academic year, interest in neurosurgery, motivating and deterring factors, and perceptions of neurosurgical exposure during undergraduate education. Statistical analyses, including chi-square and multinomial logistic regression, were applied to determine significant associations between variables. The study revealed that interest in neurosurgery was highest among first- and second-year students, with a sharp decline observed by the internship year. Primary motivators included personal interest in neuroscience and the prestige of the field. Significant deterrents were limited exposure to neurosurgery and concerns about work-life balance. A gender disparity was found, with males showing greater interest in neurosurgery, mirroring national trends in the specialty. Half of the respondents believed that neurosurgery was underrepresented in the MBBS curriculum, and most supported its inclusion as a mandatory subject. Additionally, students expressed a preference for practicing neurosurgery in India, citing familial and financial considerations as key factors. The findings emphasize the importance of early exposure, mentorship, and curriculum improvements in shaping students' career decisions. Addressing regional and gender disparities, alongside ensuring robust neurosurgical training, is essential for fostering a motivated, diverse workforce in the field of neurosurgery. R.L., S.K.S., and M.S. contributed to the conception and design of this article. M.S., A.K.D., and R.L. were responsible for the methodology and initial draft preparation. Literature search and data collection were conducted by R.L. and M.S.. The final draft was written by R.L. and M. S.. All authors reviewed, revised, and approved the final manuscript. R.L. and M.S. contributed equally to this work. Both S.K.S. and A.K.D. are corresponding authors. * Both authors contributed equally to this work. Article published online: 28 January 2026 © 2026. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) Thieme Medical and Scientific Publishers Pvt. Ltd. A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

  • Top Cited Papers

    SurgiCut-AI: an AI-driven tool for predicting surgical site infections following ventral hernia repair using pre- and intra-operative parameters

    by Rijhul Lahariya, Ashesh Kumar Jha, Mainak Sinha, Prashant Kumar Singh, Shiv Shankar Paswan, Manasi Manasvi, Manoj Kumar

    Purpose Surgical Site Infection (SSI) is the common consequence of hernia surgery. This study aimed to develop an artificial intelligence (AI)-driven predictive model for SSI following open ventral hernia repair using pre- and intra-operative parameters for early detection. Methods A prospective analysis of ventral hernia patients was conducted. Demographic, pre-operative and intra-operative parameters were collected. Feature selection using Recursive Feature Elimination (RFE) identified key predictors. Five models, eXtreme Gradient Boosting (XGBoost), logistic regression, support vector machine (SVM), Adaptive Boosting and random forest (RF), were trained and validated. Results Among 253 patients, 22 were SSI-positive. RF demonstrated the highest predictive power (area under receiver operating characteristic curve = 0.82) and diagnostic odds ratio (DOR = 55). Seven key predictors were identified: defect size area, HbA1c, lymphocytes, neutrophil-to-lymphocyte ratio, blood loss (ml), platelet count and serum albumin. Decision curve analysis showed an estimated risk stratification at an 8.3% cutoff “https://surgicut-ai.netlify.app/”. Conclusion The model’s high accuracy supports its potential for clinical decision-making. External validation is required for real-world application. Integrating this AI model into bedside tools may enhance SSI prevention, especially in resource-limited settings.


  • Open Access

    Prediction of Survival in Surgically Treated Glioblastoma Multiforme Utilizing DTI and Contrast-Enhanced MRI

    by Akhil Thomas, Mainak Sinha, Subhash Kumar, Anand K. Das, Saraj K. Singh

    Introduction Glioblastoma multiforme (GBM) is a highly malignant brain tumor with poor prognosis, despite maximal safe resection and chemoradiotherapy. Predicting survival outcomes is crucial for optimizing treatment strategies. While conventional magnetic resonance imaging (MRI) reveals tumor characteristics, advanced sequences like diffusion tensor imaging (DTI) and susceptibility-weighted imaging (SWI) may enhance prognostic accuracy. Materials and Methods A retrospective study reviewed 45 newly diagnosed GBM patients treated with maximal safe resection, adjuvant radiotherapy, and temozolomide between 2016 and 2022. Preoperative MRI data, including conventional sequences, DTI, and SWI, were analyzed. Radiological parameters—tumor volume, edema:tumor volume ratio, necrosis, enhancement, fractional anisotropy (FA), and microhemorrhage—were assessed for survival prediction. Kaplan–Meier survival analysis and Cox regression evaluated their prognostic significance. Results Among the 45 patients, the median follow-up was 58.3 weeks, with 30 deaths reported. Significant differences were observed in FA, edema:tumor volume ratio, necrosis, enhancement, and microhemorrhage between survivors and nonsurvivors. Higher edema:tumor volume ratio (cutoff ≥ 0.905, area under the curve [AUC] = 0.895) and higher FA (cutoff ≥ 0.655, AUC = 0.8) correlated with mortality and survival, respectively. Multivariate Cox regression identified edema:tumor volume ratio (hazard ratio [HR] = 7.4, p < 0.05) and microhemorrhage > 25% (HR = 45.9, p < 0.05) as independent predictors of mortality. Conclusion Tumor-related edema and necrosis significantly influence mortality, with edema:tumor volume ratio emerging as a stronger predictor than individual tumor or edema volumes. FA values reflect tumor aggressiveness, correlating with survival. Incorporating advanced imaging parameters like DTI and SWI alongside conventional MRI enhances prognostic precision in GBM management.


  • CAR T-cell therapy: a potential treatment strategy for pediatric midline gliomas

    by Anand Kumar Das, Mainak Sinha, Saraj Kumar Singh, Anurag Chaudhary, Ashim Kumar Boro, Manish Agrawal, Sona Bhardwaj, Simmi Kishore, Katyayani Kumari

    Pediatric brain tumors are the primary cause of death in children with cancer. Diffuse midline glioma (DMG) and diffuse intrinsic pontine glioma (DIPG) are frequently unresectable due to their difficult access location, and 5-year survival remains less than 20%. Despite significant advances in tumor biology and genetics, treatment options remain limited and ineffective. Immunotherapy using T cells with a chimeric antigen receptor (CAR) that has been genetically engineered is quickly emerging as a new treatment option for these patients. High levels of expression were detected for both disialoganglioside (GD2) and B7-H3 in pediatric DMG/DIPG. Numerous studies have been conducted in recent years employing various generations of GD2-CAR T cells. The two most prevalent adverse effects found with this therapy are cytokine release syndrome, which varies in severity from mild constitutional symptoms to a high-grade disease associated with potentially fatal multi-organ failure, and neurotoxicity, known as CAR T-cell-related encephalopathy syndrome. During the acute phase of anticancer action, peri-tumoral neuro-inflammation might cause deadly hydrocephalus. The initial results of clinical trials show that the outcomes are not highly encouraging as B cell malignancies and myelomas. In vivo research on CAR T-cell therapy for DIPG has yielded encouraging results, but in human trials, the early results have shown potentially fatal side effects and very modest, but fleeting improvements. Solid tumors present a hindrance to CAR T-cell therapy because of the antigenic dilemma and the strong immune-suppressing tumor microenvironment.